News

November 28, 2016November 28, 2016

Chronic Inflammation May Explain Heart Disease in Rheumatoid Arthritis

Patients with rheumatoid arthritis have chronic inflammation in the heart, which may explain the common occurrence of heart disease in this patient group. The good news is it may be ... Read more

November 23, 2016November 23, 2016

Researchers Will Use Real-Life Experiences to Gauge Impact of RA-Specific Drug Therapies

News

A new research project will investigate treatment and management options for rheumatoid arthritis (RA) by analyzing thousands of real-life experiences of RA-specific drugs. “By studying real-world experiences and stories, we can ... Read more

November 22, 2016November 22, 2016

Clinical Data Support Phase 3 Trials of Olokizumab for Rheumatoid Arthritis, R-Pharm Reports

News

R-Pharm recently reported positive results from Phase 2 clinical trials of olokizumab for the treatment of rheumatoid arthritis, supporting the drug’s move into Phase 3 testing now underway. The data was presented ... Read more

November 21, 2016November 21, 2016

Therapy for Autoimmune Diseases Like RA Shows Positive Results in Clinical Trial

News

Phase 1 trial results of an investigative selective inhibitor drug demonstrated that single or multiple oral doses of the therapy are safe and well tolerated by healthy subjects. These results ... Read more

November 18, 2016November 19, 2016

Fewer RA Patients Who Took Remicade Quit Treatment Than Those Who Used Biosimilar CT-P13

News

Treatment of rheumatoid arthritis (RA) with Remicade (infliximab) is associated with lower rates of discontinuation among patients, compared to treatment with CT-P13 (a biosimilar of infliximab), according to results presented by ... Read more

November 17, 2016November 19, 2016

Certain Rheumatoid Arthritis Patients Improved Faster with Baricitinib than Humira, Studies Show

News

Treatment with the investigative drug baricitinib is more effective than Humira (adalimumab), an FDA-approved therapy, in improving joint pain, stiffness and tiredness in patients with rheumatoid arthritis (RA) who have an ... Read more

November 16, 2016November 19, 2016

Baricitinib’s Effectiveness in Treating RA Symptoms Supported in New Analyses of Phase 3 Trials

News

New data analyses of two Phase 3 clinical trials evaluating the investigational therapy baricitinib for the treatment of rheumatoid arthritis (RA) symptoms have revealed promising results compared to conventional synthetic ... Read more

November 15, 2016November 19, 2016

Pfizer Presents New Positive Results on Xeljanz for Rheumatoid Arthritis

News

Pfizer recently presented encouraging results on the effectiveness and safety of the company’s product Xeljanz (tofacitinib citrate) for the treatment of rheumatoid arthritis (RA). The data was presented at the ACR/ARHP Annual ... Read more

November 14, 2016November 19, 2016

Study of Genetic Variant Could Lead to Better Autoimmune Disorder Therapies

News

A new study led by a research team at Oxford University suggests that pharmaceutically copying a genetic variant of a key protein could be a potential therapeutic strategy for autoimmune diseases. ... Read more

November 11, 2016November 19, 2016

New Research Looks at Thousands of RA Personal Treatment Experiences in UK

News

A new research project will investigate treatment and management options for rheumatoid arthritis (RA) by analyzing thousands of real-life experiences with RA-specific drugs. “By studying real-world experiences and stories, we can start ... Read more